|
Match
|
Document |
Document Title |
|
|
7264825 |
Pharmaceutical preparation with retarding active ingredient release, method for its production and its use
The invention describes pharmaceutical preparations with retarding active ingredient release, which consist of mixtures of powdery teicoplanin and at least one powdery, water soluble salt form of...
|
|
|
7264791 |
Method for preparing technetium-labeled antimony sulfide nanocolloid
The present invention relates to a preparation method for technetium-antimony trisulfide nanocolloid, more precisely, a preparation method for technetium-antimony trisulfide nanocolloid which is...
|
|
|
7258874 |
Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic...
|
|
|
7258850 |
Methods and compositions for treating erectile dysfunction
Methods are provided for increasing libido and/or treating erectile dysfunction in a man. The methods include the administration of a formulation testosterone alone, another fast-acting drug to...
|
|
|
7258872 |
Chromone enteric release formulation
Orally administered chromones have been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria,...
|
|
|
7258873 |
Preservation of bioactive materials by spray drying
This invention provides methods and compositions to preserve bioactive materials in a matrix of powder particles. Methods provide high-pressure gas spraying and/or near supercritical spraying of...
|
|
|
7255881 |
Metal-containing materials
Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an...
|
|
|
7255878 |
Stable benzimidazole formulation
A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric...
|
|
|
7255877 |
Fenofibrate microparticles
Fenofibrate microparticles are prepared using a combination of surface modifiers with a phospholipid. Particle size growth and stability are controlled while significantly smaller sized fenofibrate...
|
|
|
7252841 |
Rapid setting calcium phosphate cements
Methods are provided for producing compositions, e.g. pastes or clays, which rapidly set into high-strength calcium phosphate products. In the subject methods, dry reactants that include calcium...
|
|
|
7252840 |
Use of simple amino acids to form porous particles
Particles having a tap density of less than 0.4 g/cm 3 include a hydrophobic amino acid or salt thereof and a therapeutic, prophylactic or diagnostic agent or any combination thereof. Preferred...
|
|
|
7250176 |
Method of treating a bacterial infection
Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
7247312 |
Sustained-release drug formulations for implantation
The present invention relates to a formulation for implantation having a novel constitution, which accomplishes controlled releases of active ingredients. The formulation comprises one of...
|
|
|
7247319 |
Preparation of microparticles having improved flowability
Methods for preparing microparticles having improved flowability to facilitate processing in automated equipment. Microparticles are conditioned so that a flowability index of the microparticles is...
|
|
|
7247317 |
Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
Novel compositions for the treatment of IRDS and ARDS are indicated which contain a compound of formula (I), in which R1 is hydrogen or 2-(2-hydroxyethoxy)ethyl and/or a pharmacologically tolerable...
|
|
|
7244742 |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
A pharmaceutical composition comprising:
(a) an anticholinergic of formula 1
wherein X − is an anion with a single negative charge;
(b) a corticosteroid; and (c) a...
|
|
|
7244439 |
Cosmetic composition
A cosmetic composition having excellent application feeling and transparency while maintaining covering power which includes (a) composite particles obtained by allowing at least two kinds of...
|
|
|
7244451 |
Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
The present invention is directed to nanoparticulate compositions comprising a poorly soluble drug and at least one copolymer of vinyl pyrrolidone and vinyl acetate as a surface stabilizer adsorbed...
|
|
|
7241459 |
Polymers containing bioactive glass with antimicrobial effect
The method of protecting a polymeric plastic from attack by bacteria and fungi includes providing bioactive glass particles having a mean particles size preferably less than 2 μm as an additive...
|
|
|
7241813 |
End-capped polymers and compositions containing such compounds
End-capped polymers, methods for making those end-capped polymers and compositions containing those end-capped polymers are disclosed. One of the disclosed end-capped copolymers has the formula:
...
|
|
|
7241458 |
Antiviral compositions
The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These...
|
|
|
7238364 |
Compliant tissue sealants
An improved barrier or drug delivery system which is highly adherent to the surface to which it is applied is disclosed, along with methods for making the barrier. In the preferred embodiment, the...
|
|
|
RE39713 |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages
Water-soluble macromers including at least one hydrolysable linkage formed from carbonate or dioxanone groups, at least one water-soluble polymeric block, and at least one polymerizable group, and...
|
|
|
7238371 |
Triggered release from proteinoid microspheres
The invention provides proteinoid microsphere made up of a mixture of thermally condensed amino acids that are crosslinked with a bis dithiol crosslinker reagent. The proteinoid microspheres of the...
|
|
|
7238366 |
Submicron liposome suspensions obtained from preliposome lyophilizates
This invention provides an aqueous/t-butanol solvent-system, facile reconstitute, submicron-reconsitiute preliposome-lyophilaye and method of its preparation and use. In one embodiment this...
|
|
|
7238370 |
Method and composition to prevent and treat photoaging of skin
A method and composition for stimulating skin function to prevent and reverse the effects of photoaging, without removal of the protective stratum corneum. The composition of the invention is a...
|
|
|
7235527 |
Protein and process for producing the same
A protein consisting of the amino acid sequence in SEQ ID No: 1 derived from human MP52 and a homodimer protein thereof useful for treating cartilage and/or bone diseases and a process for its...
|
|
|
7235260 |
Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor
Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such...
|
|
|
7235297 |
Amphiphile solid support for peptide synthesis, bioorganic and organic chemistry
The present invention fulfils desired specifications generally rarely encountered with existing solid supports such as highly amphiphile behaviour. The solid support described herein is a...
|
|
|
7235228 |
Fluorescent-magnetic nanoparticles with core-shell structure
This invention comprises nanoparticles for use with biosensors. The nanoparticles have core/shell architecture. The nanoparticles can be detected by two means, magnetic and optical by virtue of the...
|
|
|
7232577 |
Readily dispersible dietary fiber composition
The present invention includes a dispersible dietary fiber composition comprising a colloidal silicon dioxide and a substantially uncoated, fibrous, vegetable material powder that is not naturally...
|
|
|
7229645 |
Spray freeze-dried compositions
A process for producing a powder comprises spray freeze-drying an aqueous solution or suspension comprising a pharmaceutical agent, said solution or suspension having a solids content of 20% by...
|
|
|
7229607 |
Treatment of respiratory disease
A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect...
|
|
|
7229642 |
Amino acid modulated extended release dosage form
Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
|
|
|
7226619 |
Material for controlling diversion of medications
A combination of a pro-agonist first medication in timed release form, and a sequestered second non-antagonist medication allows the first medication to be effective if taken according to medical...
|
|
|
7226620 |
Directly compressible tricalcium phosphate
A compressible tricalcium phosphate agglomerate comprises tricalcium phosphate particles, each having an outer surface, and a binder comprising a polyvinylpyrollidone, carrageenan, or a guar gum,...
|
|
|
7226617 |
Thermosensitive and biodegradable microgel and a method for the preparation thereof
The present invention provides a thermosensitive and biodegradable microgel and a method of synthesizing such microgels. The thermosensitive and biodegradable microgel is synthesized from a...
|
|
|
7226622 |
Chemoablation of tissue using biodegradable, solid salt dosage forms
Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w...
|
|
|
7226608 |
Topical use of microfine calcined alumina
Dispersions containing from about 0.5% to about 30% by weight dispersed microfine calcined alumina, stainless steel, or gold particles typically having particle size of less than about 5μ, more...
|
|
|
7226618 |
Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
A suspension of vector particles (PV) based on polyamino acids and have a mean hydrodynamic diameter between 30 and 120 nm, and an insulin load factor of from 5 to 25% of associated insulin volume...
|
|
|
7226607 |
Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer
Compositions for providing controlled-release of an active material comprise a dispersant and microcapsules containing the active material and a stabilizer. The compositions contain the dispersant...
|
|
|
7223420 |
Powder mixture for resorbable calcium phosphate biocements
The present invention relates to a powder mixture for resorbable calcium phosphate biocements, which mixture consists of 40–99% by volume of powder having a particle size of 0.1–10 μm, 1–20%...
|
|
|
7223419 |
Production process for polymeric micelle charged therein with drug and polymeric micelle composition
Provided are a production process for a polymeric micelle which is stable and has a high drug content and a composition containing such polymeric micelle. Disclosed are a production process for a...
|
|
|
7220433 |
Compositions for parenteral administration and sustained-release of therapeutic agents
The present invention is directed to parenterally-administrable microparticles for providing sustained-release of a therapeutic agent in the body, where the microparticles include a polymeric core...
|
|
|
7220435 |
Process for the production of glycine enriched NaCI crystals with improved flow
The present invention relates to a simple, economical, and efficient cyclic process for producing rhombic dodecahedron shaped glycine enriched, free flowing common salt from brine, said process...
|
|
|
7217427 |
Polymersomes and related encapsulating membranes
The present invention provides biocompatible vesicles comprising semi-permeable, thin-walled encapsulating membranes which are formed in an aqueous solution, and which comprise one or more...
|
|
|
7217432 |
Vegetable substitute for lanolin
Lanolin-free lanolin substitute compositions comprising: A) from about 50 to about 95% by weight, of at least one plant sterol fatty acid ester; B) from about 1 to about 10% by weight, of at least...
|
|
|
7214387 |
Sustained release formulations of metformin
The invention provides sustained release formulations of metformin or a pharmaceutically acceptable salt thereof, and methods of treating diabetes by administering to a patient a therapeutically...
|
|
|
7214427 |
Composite beads comprising magnetizable substance and electro-conductive substance
This invention relates generally to the field of moiety or molecule isolation, detection and manipulation and library synthesis. In particular, the invention provides a bead, which bead comprises:...
|
|
|
7214364 |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae,...
|